РАННИЕ НЕЙРОПСИХОЛОГИЧЕСКИЕ РАССТРОЙСТВА ПРИ БОЛЕЗНИ ПАРКИНСОНА.
##semicolon##
https://doi.org/10.1808/kdt6nm80Abstrak
оценка клинических особенностей эмоционально-аффективных и когнитивных нарушений на ранних стадиях развития БП.
##submission.citations##
Hoehn M, Yahr M. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427-427. https://doi.org/10.1212/WNL.17.5.427
Shaw KM, Lees AJ, Stern GM. The impact of treatment with levodopa on Parkinson’s disease. Quarterly Journal of Medicine. 1980;49(3):283-293. https://doi.org/10.1093/oxfordjournals.qjmed.a067623
Clarke CE. Mortality from Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;68(2):254-255. https://doi.org/10.1136/jnnp.68.2.254
Curtis L, Lees A, Stern G, Marmot M. Effect of L-Dopa on course of Parkinson’s disease. The Lancet. 1984;324(8396):211-212. https://doi.org/10.1016/S0140-6736(84)90493-8
Marttila R, Rinne U, Siirtola T, Sonninen V. Mortality of patients with parkinson’s disease treated with levodopa. Journal of Neurology. 1977;216(3):147-153. https://doi.org/10.1007/BF00313615
Левин О.С. Феноменология и лечение декомпенсации болезни Паркинсона. Неврологический журнал. 2007;1:8-15. [Levin OS. Fenomenologia i lechenie decompensazii bolezni Parkinsona. Nevrologicheskiy Jurnal. 2007;1:8-15. (In Russ.)].
Экстрапирамидные расстройства. Руководство по диагностике и лечению. Под ред. Штока В.Н., Ивановой-Смоленской И.А., Левина О.С. М.: МЕДпресс-информ; 2002. [Shtok VN. Ekstrapiramidnye rasstroistva. Rukovodstvo po diagnostike i lecheniyu. In: V.N. Shtok, I.A. IvanovaSmolenskaya, O.S. Levin, eds. M.: MEDpress-inform; 2002. (In Russ.)].
Fahn S. Parkinson’s disease: 10 years of progress, 1997—2007. Mov Disord. 2010;25(1):2-14. https://doi.org/10.1002/mds.22796
Guttman M, Slaughter P, Theriault M, DeBoer D, Naylor C. Parkinsonism in Ontario: Increased mortality compared with controls in a large cohort study. Neurology. 2001;57(12):2278-2282. https://doi.org/http://dx.doi.org/10.1212/WNL.57.12.2278
Hely M, Morris J, Reid W, Trafficante R. Sydney multicenter study of Parkinson’s disease: Non-L-dopa-responsive problems dominate at 15 years. Movement Disorders. 2005;20(2):190-199. https://doi.org/10.1002/mds.20324
Herlofson K, Lie S, Arsland D, Larsen J. Mortality and Parkinson disease: A community based study. Neurology. 2004;62(6):937-942. https://doi.org/10.1212/01.wnl.0000115116.56955.
Muller J, Wenning G, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study. Neurology. 2000;55(6):888-891. https://doi.org/http://dx.doi.org/10.1212/WNL.55.6.888
Morgan J, Currie L, Harrison M, Bennett J, Trugman J, Wooten G. Mortality in Levodopa-Treated Parkinson’s Disease. Parkinson’s Disease. 2014:1-8. https://doi.org/http://dx.doi.org/2014/426976
Louis E, Marder K, Cote L, Tang M, Mayeux R. Mortality From Parkinson Disease. Archives of Neurology. 1997;54(3):260-264. https://doi.org/10.1001/archneur.1997.00550150024011
Marder K, Leung D, Tang M, Bell K, Dooneief G, Cote L, Stern Y, Mayeux R. Are demented patients with Parkinson’s disease accurately reflected in prevalence surveys? A survival analysis. Neurology. 1991;41(8): 1240-1240. https://doi.org/http://dx.doi.org/10.1212/WNL.41.8.1240
Levy G, Tang MX, Louis ED et al. The association of incident dementia with mortality in PD. Neurology. 2002;59(11):1708-1713. https://doi.org/http://dx.doi.org/10.1212/01.WNL.0000036610.36834.E0
De Lau L, Breteler M. Epidemiology of Parkinson’s disease. The Lancet Neurology. 2006;5(6):525-535. https://doi.org/http://dx.doi.org/10.1016/S1474-4422(06)70471-9
D Lau L, Schipper C, Hofman A, Koudstaal P, Breteler M. Prognosis of Parkinson’s Disease. Arch Neurol. 2005;62(8):1265. https://doi.org/10.1001/archneur.62.8.1265
Hughes T, Ross H, Mindham R, Spokes E. Mortality in Parkinson’s disease and its association with dementia and depression. Acta Neurologica Scandinavica. 2004;110(2):118-123. https://doi.org/10.1111/j.1600-0404.2004.00292.x
Diem-Zangerl A, Seppi K, Wenning G, Trinka E, Ransmayr G, Oberaigner W, Poewe W. Mortality in Parkinson’s disease: A 20-year follow-up study. Movement Disorders. 2009;24(6):819-825. https://doi.org/10.1002/mds.22414
Rajput AH, Uitti RJ, Rajput A, Offord KP. Mortality in Parkinson’s disease. Mov Disord. 2010;25:507-
Zafarjon o‘g‘li, Muydinov Muhammadzoir. "SHOYIM BO ‘TAYEV HIKOYALARIDA XARAKTERLAR TASVIRI." Konferensiyalar| Conferences. Vol. 1. No. 4. 2024.
Zafarjon o'g'li, Muydinov Muhammadzoir. "ANVAR OBIDJON ASARLARINING NASRIY POETIKASI." (2023).
Zafarjon o'g'li, Muydinov Muhammadzoir. "ANVAR OBIDJONNING IJOD LABARATORIYASINING SHAKLLANISHIGA BIR NAZAR." (2023).
